Join

Compare · PAVM vs RMD

PAVM vs RMD

Side-by-side comparison of PAVmed Inc. (PAVM) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both PAVM and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • RMD is the larger of the two at $29.87B, about 294.5x PAVM ($101.4M).
  • Over the past year, PAVM is down 65.5% and RMD is down 13.3% - RMD leads by 52.3 points.
  • PAVM has been more active in the news (14 items in the past 4 weeks vs 6 for RMD).
  • RMD has more recent analyst coverage (25 ratings vs 0 for PAVM).
PerformancePAVM-65.53%RMD-13.25%
2025-05-01+0.00%2026-05-01
MetricPAVMRMD
Company
PAVmed Inc.
ResMed Inc.
Price
$8.48-2.42%
$205.03-3.96%
Market cap
$101.4M
$29.87B
1M return
-12.98%
-8.00%
1Y return
-65.53%
-13.25%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2016
News (4w)
14
6
Recent ratings
0
25
PAVM

PAVmed Inc.

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.

RMD

ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.